BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Alcon, Inc. Waives Minimum Acceptance Condition for WaveLight

  September 11, 2007

   · 

  1 min read
• BioCapital

  RegeneRx Biopharmaceuticals, Inc. Receives U.S. Patent for Wound Healing Technology

  September 11, 2007

   · 

  1 min read
• Drug Development

  NicOx SA Reports Topigen Pharmaceuticals Inc. to Advance TPI-1020 into Phase 2 for COPD Following Promising Clinical Results

  September 11, 2007

   · 

  1 min read
• Policy

  Basilea Pharmaceutica Announces the Submissions of Marketing Authorization Applications in the EU for Alitretinoin, an Investigational Drug for the Treatment of Severe Refractory Chronic Hand Eczema

  September 11, 2007

   · 

  1 min read
• Policy

  Theratechnologies Inc. Learns from the FDA that its Tesamorelin Clinical Program is Moving in the Right Direction

  September 11, 2007

   · 

  1 min read
• Oncologix Tech, Inc. Issues Letter to Shareholders Regarding Upcoming Events and Milestones

  September 11, 2007

   · 

  1 min read
• Biotech Bay

  INBONE Technologies, Inc. Files 25th Patent Application

  September 11, 2007

   · 

  1 min read
• Drug Development

  Phenomix Corporation Initiates Phase 2b Clinical Trial of PHX1149 for Type 2 Diabetes; Will Present PHX1149 Data at EASD

  September 11, 2007

   · 

  1 min read
• Drug Development

  Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis

  September 11, 2007

   · 

  1 min read
• Business

  Alltracel Pharmaceuticals Plc Announces Interim Results

  September 11, 2007

   · 

  1 min read